Dezhou People's Hospital,Shandong Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4

Organization Overview

First Clinical Trial
2015
NCT02550080
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Dezhou People's Hospital

Active Ingredients

Drugs in Phase 4 Trials (1)

dapsone (aczone) (1 trial)

Drugs in Phase 3 Trials (1)

borneol (1 trial)

Drugs in Phase 2 Trials (2)

cyclosporine (sandimmune) (1 trial)

umbilical cord mesenchymal stem cells (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hypersensitivity (Phase 4)

Leprosy (Phase 4)

Pneumonia, Pneumocystis (Phase 4)

Skin Diseases (Phase 4)

Skin Diseases, Vesiculobullous (Phase 4)

Urticaria (Phase 4)

Vasculitis (Phase 4)

Vasculitis, Leukocytoclastic, Cutaneous (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 4